identification of biomarkers for stage prediction in papillary renal cell carcinoma
Clicks: 187
ID: 140831
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
187 views
45 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #4 of 10 articles by views in legal reference services quarterly
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Papillary Renal Cell Carcinoma (PRCC) is a heterogeneous disease accounting for 10%-15% of renal cell carcinomas. A comprehensive analysis is required to find the genes that are responsible for the stage progression in PRCC. The advent of next generation sequencing techniques (NGS) has produced a lot of high throughput data from patients that can be analyzed to address this problem. The low sample size, noise and high dimensionality of the data though enhances the complexity, requiring the use of sophisticated methods. In our study we propose a machine learning pipeline fulfilling a two-fold objective: 1) To find suitable genes that could serve as potential biomarkers for stage progression in PRCC. 2) To build a classifier using the above biomarkers that can predict the stage of a given patient. The RNA-Seq data of PRCC was taken and divided into training set (80%) and test set (20%). Different groupings of training data were created and on each group different feature selection algorithms. The features (genes) extracted were then combined based on voting. The selected features from each feature selection algorithm were then used to train the classifiers on the training data. The performance of the model on the test data was evaluated using various measures. To further check the quality of the genes a 10 fold cross validation was performed on microarray cohort of PRCC. The selected genes we get are robust with overlap among the features derived from the various feature selection algorithms. The best of the classifiers trained above gave an accuracy > 86 % and area under Receiver Operating Curve (AUC) > 0.8. The 10 fold cross validation on microarray data using the above features yields best accuracy > 85 % and AUC > 0.84 enhancing our confidence on our gene sets. The feature sets which we get could be further investigated for identifying their role in stage progression. Further our pipeline could be used for analyzing other cancer data sets.
| Reference Key |
singh2017canadianidentification
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Noor Pratap Singh;Raju S. Bapi;P.K. Vinod |
| Journal | legal reference services quarterly |
| Year | 2017 |
| DOI |
10.24870/cjb.2017-a59
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.